HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial
Llombart-Cussac, Antonio, MD, Cortés, Javier, MD, Paré, Laia, PhD, Galván, Patricia, BS, Bermejo, Begoña, MD, Martínez, Noelia, MD, Vidal, Maria, MD, Pernas, Sònia, MD, López, Rafael, MD, Muñoz, Montserrat, MD, Nuciforo, Paolo, MD, Morales, Serafín, MD, Oliveira, Mafalda, MD, de la Peña, Lorena, PhD, Peláez, Alexandra, MD, Prat, Aleix, Dr
Published in The lancet oncology (01.04.2017)
Published in The lancet oncology (01.04.2017)
Get full text
Journal Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Brasó-Maristany, Fara, Griguolo, Gaia, Pascual, Tomás, Paré, Laia, Nuciforo, Paolo, Llombart-Cussac, Antonio, Bermejo, Begoña, Oliveira, Mafalda, Morales, Serafín, Martínez, Noelia, Vidal, Maria, Adamo, Barbara, Martínez, Olga, Pernas, Sonia, López, Rafael, Muñoz, Montserrat, Chic, Núria, Galván, Patricia, Garau, Isabel, Manso, Luis, Alarcón, Jesús, Martínez, Eduardo, Gregorio, Sara, Gomis, Roger R., Villagrasa, Patricia, Cortés, Javier, Ciruelos, Eva, Prat, Aleix
Published in Nature communications (20.01.2020)
Published in Nature communications (20.01.2020)
Get full text
Journal Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Prat, Aleix, Pascual, Tomás, De Angelis, Carmine, Gutierrez, Carolina, Llombart-Cussac, Antonio, Wang, Tao, Cortés, Javier, Rexer, Brent, Paré, Laia, Forero, Andres, Wolff, Antonio C, Morales, Serafín, Adamo, Barbara, Brasó-Maristany, Fara, Vidal, Maria, Veeraraghavan, Jamunarani, Krop, Ian, Galván, Patricia, Pavlick, Anne C, Bermejo, Begoña, Izquierdo, Miguel, Rodrik-Outmezguine, Vanessa, Reis-Filho, Jorge S, Hilsenbeck, Susan G, Oliveira, Mafalda, Dieci, Maria Vittoria, Griguolo, Gaia, Fasani, Roberta, Nuciforo, Paolo, Parker, Joel S, Conte, PierFranco, Schiff, Rachel, Guarneri, Valentina, Osborne, C Kent, Rimawi, Mothaffar F
Published in JNCI : Journal of the National Cancer Institute (01.01.2020)
Published in JNCI : Journal of the National Cancer Institute (01.01.2020)
Get full text
Journal Article
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
Schmid, Peter, Cortes, Javier, Joaquim, Ana, Jañez, Noelia Martínez, Morales, Serafín, Díaz-Redondo, Tamara, Blau, Sibel, Neven, Patrick, Lemieux, Julie, García-Sáenz, José Ángel, Hart, Lowell, Biyukov, Tsvetan, Baktash, Navid, Massey, Dan, Burris, 3rd, Howard A, Rugo, Hope S
Published in Breast cancer research : BCR (12.06.2023)
Published in Breast cancer research : BCR (12.06.2023)
Get full text
Journal Article
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study
Martín, Miguel, Loibl, Sibylle, von Minckwitz, Gunter, Morales, Serafín, Martinez, Noelia, Guerrero, Angel, Anton, Antonio, Aktas, Bahriye, Schoenegg, Winfried, Muñoz, Montserrat, Garcia-Saenz, José Ángel, Gil, Miguel, Ramos, Manuel, Margeli, Mireia, Carrasco, Eva, Liedtke, Cornelia, Wachsmann, Grischa, Mehta, Keyur, De la Haba-Rodriguez, Juan R
Published in Journal of clinical oncology (20.03.2015)
Published in Journal of clinical oncology (20.03.2015)
Get full text
Journal Article
Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
Pont, Mariona, Marqués, Marta, Sorolla, Maria Alba, Parisi, Eva, Urdanibia, Izaskun, Morales, Serafín, Salud, Antonieta, Sorolla, Anabel
Published in Cancers (01.09.2023)
Published in Cancers (01.09.2023)
Get full text
Journal Article
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study
Alés-Martínez, José Enrique, Balmaña, Judith, Sánchez-Rovira, Pedro, Salvador Bofill, Francisco Javier, García Sáenz, Jose Ángel, Pimentel, Isabel, Morales, Serafín, Fernández-Abad, María, Lahuerta Martínez, Ainhara, Ferrer, Neus, Zamora, Pilar, Bermejo, Begoña, Díaz-Redondo, Tamara, López-Ceballos, María Helena, Galán, María, Pérez-Escuredo, Jhudit, Calabuig, Laura, Sampayo, Miguel, Pérez-Garcia, José Manuel, Cortés, Javier, Llombart-Cussac, Antonio
Published in Breast (Edinburgh) (01.10.2024)
Published in Breast (Edinburgh) (01.10.2024)
Get full text
Journal Article
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier
Published in Breast cancer research : BCR (15.01.2021)
Published in Breast cancer research : BCR (15.01.2021)
Get full text
Journal Article
Web Resource
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Gavilá, Joaquín, Oliveira, Mafalda, Pascual, Tomás, Perez-Garcia, Jose, Gonzàlez, Xavier, Canes, Jordi, Paré, Laia, Calvo, Isabel, Ciruelos, Eva, Muñoz, Montserrat, Virizuela, Juan A, Ruiz, Isabel, Andrés, Raquel, Perelló, Antonia, Martínez, Jerónimo, Morales, Serafín, Marín-Aguilera, Mercedes, Martínez, Débora, Quero, Juan C, Llombart-Cussac, Antonio, Prat, Aleix
Published in BMC medicine (09.01.2019)
Published in BMC medicine (09.01.2019)
Get full text
Journal Article
Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial
Fullana, Bartomeu, Morales, Serafín, Petit, Anna, Alay, Ania, Verdaguer, Helena, Climent, Fina, Navarro-Perez, Valentí, Cejuela, Mónica, Galvan, Patricia, Gumà, Anna, Llombart-Cussac, Antonio, Cordero, David, Casanovas, Oriol, Prat, Aleix, Gil-Gil, Miguel, Pernas, Sonia
Published in Scientific reports (09.10.2024)
Published in Scientific reports (09.10.2024)
Get full text
Journal Article
Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
Marqués, Marta, Sorolla, Maria Alba, Urdanibia, Izaskun, Parisi, Eva, Hidalgo, Iván, Morales, Serafín, Salud, Antonieta, Sorolla, Anabel
Published in Cancers (22.02.2022)
Published in Cancers (22.02.2022)
Get full text
Journal Article
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
Martín, Miguel, Zielinski, Christoph, Ruiz-Borrego, Manuel, Carrasco, Eva, Ciruelos, Eva M., Muñoz, Montserrat, Bermejo, Begoña, Margelí, Mireia, Csöszi, Tibor, Antón, Antonio, Turner, Nicholas, Casas, María I., Morales, Serafín, Alba, Emilio, Calvo, Lourdes, de la Haba-Rodríguez, Juan, Ramos, Manuel, Murillo, Laura, Santaballa, Ana, Alonso-Romero, José L., Sánchez-Rovira, Pedro, Corsaro, Massimo, Huang, Xin, Thallinger, Christiane, Kahan, Zsuzsanna, Gil-Gil, Miguel
Published in European journal of cancer (1990) (01.06.2022)
Published in European journal of cancer (1990) (01.06.2022)
Get full text
Journal Article
Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer
Ciruelos, Eva María, Díaz, María Nieves, Isla, María Dolores, López, Rafael, Bernabé, Reyes, González, Encarnación, Cirauqui, Beatriz, Coves, Juan, Morales, Serafín, Arcediano, Alberto, Barneto, Isidoro, Cerezuela, Pablo, Illarramendi, José Juan, Morales, Cristina, Ponce, Santiago
Published in European journal of cancer care (01.11.2019)
Published in European journal of cancer care (01.11.2019)
Get full text
Journal Article
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study
Gil-Gil, Miguel J., Bellet, Meritxell, Bergamino, Milana, Morales, Serafín, Barnadas, Agustí, Manso, Luís, Saura, Cristina, Fernández-Ortega, Adela, Garcia-Martinez, Elena, Martinez-Jañez, Noelia, Melé, Mireia, Villagrasa, Patricia, Celiz, Pamela, Perez Martin, X., Ciruelos, Eva, Pernas, Sonia
Published in Frontiers in oncology (09.07.2021)
Published in Frontiers in oncology (09.07.2021)
Get full text
Journal Article
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Manso, Luis, Hernando, Cristina, Galán, María, Oliveira, Mafalda, Cabrera, Miguel A., Bratos, Raquel, Rodríguez, César A., Ruiz-Borrego, Manuel, Blanch, Salvador, Llombart-Cussac, Antonio, Delgado-Mingorance, Juan I., Álvarez-Busto, Iñaki, Gallegos, Isabel, González-Cortijo, Lucía, Morales, Serafín, Aguirre, Elena, Hernando, Blanca A., Ballesteros, Ana, Alés-Martínez, José E., Reboredo, Cristina, Oltra, Amparo, González-Cao, María, Santisteban, Marta, Malón, Diego, Echeverría, Isabel, García-Garre, Elisa, Vega, Estela, Servitja, Sònia, Andrés, Raquel, Robles, Carlos E., López, Rafael, Galve, Elena, Echarri, María J., Legeren, Marta, Moreno, Fernando
Published in Breast (Edinburgh) (01.12.2020)
Published in Breast (Edinburgh) (01.12.2020)
Get full text
Journal Article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
Pascual, Tomás, Oliveira, Mafalda, Villagrasa, Patricia, Ortega, Vanesa, Paré, Laia, Bermejo, Begoña, Morales, Serafín, Amillano, Kepa, López, Rafael, Galván, Patricia, Canes, Jordi, Salvador, Fernando, Nuciforo, Paolo, Rubio, Isabel T., Llombart-Cussac, Antonio, Di Cosimo, Serena, Baselga, José, Harbeck, Nadia, Prat, Aleix, Cortés, Javier
Published in NPJ breast cancer (25.11.2021)
Published in NPJ breast cancer (25.11.2021)
Get full text
Journal Article
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer
Llombart-Cussac, Antonio, Bermejo, Begoña, Villanueva, Cristian, Delaloge, Suzette, Morales, Serafín, Balmaña, Judith, Amillano, Kepa, Bonnefoi, Hervé, Casas, Ana, Manso, Luis, Roché, Henri, Gonzalez-Santiago, Santiago, Gavilá, Joaquín, Sánchez-Rovira, Pedro, Di Cosimo, Serena, Harbeck, Nadia, Charpentier, Eric, Garcia-Ribas, Ignacio, Radosevic-Robin, Nina, Aura, Claudia, Baselga, Jose
Published in Breast cancer research and treatment (01.11.2015)
Published in Breast cancer research and treatment (01.11.2015)
Get full text
Journal Article
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer
Martín, Miguel, González-Rivera, Milagros, Morales, Serafín, de la Haba-Rodriguez, Juan, González-Cortijo, Lucía, Manso, Luis, Albanell, Joan, González-Martín, Antonio, González, Sónia, Arcusa, Angels, de la Cruz-Merino, Luis, Rojo, Federico, Vidal, María, Galván, Patricia, Aguirre, Elena, Morales, Cristina, Ferree, Sean, Pompilio, Kristen, Casas, Maribel, Caballero, Rosalía, Goicoechea, Uxue, Carrasco, Eva, Michalopoulos, Steven, Hornberger, John, Prat, Aleix
Published in Current medical research and opinion (01.06.2015)
Published in Current medical research and opinion (01.06.2015)
Get more information
Journal Article
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Pascual, Tomás, Martin, Miguel, Fernández-Martínez, Aranzazu, Paré, Laia, Alba, Emilio, Rodríguez-Lescure, Álvaro, Perrone, Giuseppe, Cortés, Javier, Morales, Serafín, Lluch, Ana, Urruticoechea, Ander, González-Farré, Blanca, Galván, Patricia, Jares, Pedro, Rodriguez, Adela, Chic, Nuria, Righi, Daniela, Cejalvo, Juan Miguel, Tonini, Giuseppe, Adamo, Barbara, Vidal, Maria, Villagrasa, Patricia, Muñoz, Montserrat, Prat, Aleix
Published in Frontiers in oncology (26.04.2019)
Published in Frontiers in oncology (26.04.2019)
Get full text
Journal Article
Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer
Turner, Nicholas C., Oliveira, Mafalda, Howell, Sacha J., Dalenc, Florence, Cortes, Javier, Gomez Moreno, Henry L., Hu, Xichun, Jhaveri, Komal, Krivorotko, Petr, Loibl, Sibylle, Morales Murillo, Serafin, Okera, Meena, Park, Yeon Hee, Sohn, Joohyuk, Toi, Masakazu, Tokunaga, Eriko, Yousef, Samih, Zhukova, Lyudmila, de Bruin, Elza C., Grinsted, Lynda, Schiavon, Gaia, Foxley, Andrew, Rugo, Hope S.
Published in The New England journal of medicine (01.06.2023)
Published in The New England journal of medicine (01.06.2023)
Get full text
Journal Article